Andrew J. Tofe

Sites and Mechanisms of Localization of Technetium-99m Phosphorus Radiopharmaceuticals in Acute Myocardial Infarcts and other Tissues

L. Maximilian Buja, Andrew J. Tofe, Padmakar V. Kulkarni et al. · Journal of Clinical Investigation · 1977 · 209 citations · Full text

Medicine, Cardiology, Nuclear Medicine +13

Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy.

Marco Chinol, Shankar Vallabhajosula, Stanley J. Goldsmith et al. · PubMed · 1993 · 100 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.

John A. Bevan, Andrew J. Tofe, James J. Benedict et al. · PubMed · 1980 · 40 citations

Medicine, Nuclear Medicine, Pharmacokinetics +15

Clinical, Radiographic, Histologic, and Histomorphometric Comparison of PepGen P-15 Particulate and PepGen P-15 Flow in Extraction Sockets: A Same-Mouth Case Study

Jack Hahn, Michael D. Rohrer, Andrew J. Tofe · Implant Dentistry · 2003 · 28 citations

Dentistry, Dental Biomaterials Science, Periodontics +17

Factors affecting uptake and retention of technetium-99m-diphosphonate and 99m-pertechnetate in osseous, connective and soft tissues

Marion D. Francis, Candice L. Slough, Andrew J. Tofe et al. · Calcified Tissue International · 1976 · 28 citations

Medicine, Nuclear Medicine, Pharmacokinetics +11